immunity News and Research

RSS

Scientists shed light on the history of Zika virus in Thailand

The circulation of the dengue virus for the past sixty years in South-East Asia is relatively well known. For Zika, the situation is much less clear.

28 Feb 2019

Researchers are developing and testing novel gene therapy to cure Crigler-Najjar syndrome

Crigler-Najjar syndrome affects about one in a million people at birth. Because of a defective gene, these individuals lack an essential enzyme in their liver to eliminate bilirubin, a toxic bile pigment that accumulates in all body tissues causing jaundice and potentially leading to irreversible and lethal neurological damage.

28 Feb 2019

Breast cancer survivors more optimistic about changes occurred due to their illness

Two years after diagnosis, breast cancer survivors have four times more positive than negative thoughts about changes they experienced because of their illness, a new study found.

27 Feb 2019

Study: Chikungunya virus arrived in Brazil at least one year before it was detected

New evidence suggests that Chikungunya virus arrived in Brazil at least one year earlier than it was detected by public health surveillance systems.

26 Feb 2019

Scientists use CRISPR to reveal the secret life of antimicrobial peptides

When it comes to the immune system, we usually think about lymphocytes like B and T cells or macrophages going on constant seek-and-destroy missions against invading pathogens like bacteria and viruses.

26 Feb 2019

New protein 'switch' could stop progression of blood-poisoning and increase chances of survival

Scientists at the University of British Columbia have discovered a new protein "switch" that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.

26 Feb 2019

Study findings can help develop new drugs for ischemia

Russian scientists investigated the role of opioid receptors in protecting the heart from coronary disease: the lack of its blood supply.

25 Feb 2019

A parent-to-parent campaign to get vaccine rates up

In 2017, Kim Nelson had just moved her family back to her hometown in South Carolina. Boxes were still scattered around the apartment, and while her two young daughters played, Nelson scrolled through a newspaper article on her phone.

25 Feb 2019

Reduced antibody adaptability may make the elderly more vulnerable to influenza

The influenza vaccine may be less effective in the elderly because their B cells are less capable of producing antibodies that can adapt to protect against new viral strains, researchers report February 19 in the journal Cell Host & Microbe.

21 Feb 2019

Analysis of cervical precancer shows decline in two strains of HPV

An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease.

21 Feb 2019

Mayo clinic researchers discuss local case studies of leprosy

Leprosy has a history that has spanned centuries and societies across the globe. Yet, it continues to be a problem -- even in the modern era.

21 Feb 2019

Viruses in the intestinal tracts can lead to islet autoimmunity and Type 1 diabetes

Researchers at the Center for Infection and Immunity at the Columbia University Mailman School of Public Health and the University of New South Wales, Sydney, Australia, provide new evidence supporting an association between elevated levels of enteroviruses in the intestinal tracts of children and islet autoimmunity, a precursor to Type 1 diabetes.

20 Feb 2019

Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing

Developed by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models.

20 Feb 2019

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

20 Feb 2019

Study finds new link between food allergies and multiple sclerosis

Like many other medical conditions, the mechanism of multiple sclerosis remains an enigma--a puzzle composed of complex genetic and environmental factors. A key piece to this puzzle is the immune system, which is also responsible for regulating many other physiological (and pathological) phenomena--including allergies.

19 Feb 2019

Single CRISPR treatment can safely and stably correct genetic disease

Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease -- Duchenne muscular dystrophy (DMD) -- for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.

18 Feb 2019

CRISPR technology creates pluripotent stem cells that are 'invisible' to the immune system

UC San Francisco scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally "invisible" to the immune system, a feat of biological engineering that, in laboratory studies, prevented rejection of stem cell transplants.

18 Feb 2019

Darla Shine joins anti-vaccination campaigners, increases threat of measles outbreak in US

Darla Shine has recently joined anti-vaccination campaigners by claiming that having measles as a child could protect against cancer in later life.

15 Feb 2019

Immune checkpoint molecule protects against future development of cancer

A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.

15 Feb 2019

Researchers comprehensively sequence the human immune system

For the first time ever, researchers are comprehensively sequencing the human immune system, which is billions of times larger than the human genome. In a new study published in Nature from the Human Vaccines Project, scientists have sequenced a key part of this vast and mysterious system -- the genes encoding the circulating B cell receptor repertoire.

14 Feb 2019

immunity News and Research

Scientists shed light on the history of Zika virus in Thailand

Researchers are developing and testing novel gene therapy to cure Crigler-Najjar syndrome

Breast cancer survivors more optimistic about changes occurred due to their illness

Study: Chikungunya virus arrived in Brazil at least one year before it was detected

Scientists use CRISPR to reveal the secret life of antimicrobial peptides

New protein 'switch' could stop progression of blood-poisoning and increase chances of survival

Study findings can help develop new drugs for ischemia

A parent-to-parent campaign to get vaccine rates up

Reduced antibody adaptability may make the elderly more vulnerable to influenza

Analysis of cervical precancer shows decline in two strains of HPV

Mayo clinic researchers discuss local case studies of leprosy

Viruses in the intestinal tracts can lead to islet autoimmunity and Type 1 diabetes

Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing

New screening method could catch organ rejection much earlier without a biopsy needle

Study finds new link between food allergies and multiple sclerosis

Single CRISPR treatment can safely and stably correct genetic disease

CRISPR technology creates pluripotent stem cells that are 'invisible' to the immune system

Darla Shine joins anti-vaccination campaigners, increases threat of measles outbreak in US

Immune checkpoint molecule protects against future development of cancer

Researchers comprehensively sequence the human immune system

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News